CIK 0001420800 · Large accelerated filer
Enovis CORP
Sign in to watch- Ticker
- ENOV
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 541887631
- Phone
- (302) 252-9160
- Business address
- 2900 LAKE VISTA DRIVE, SUITE 200, LEWISVILLE, TX, 75067
- Former names
- Colfax CORP
- Open-market buys, last 90 days
- $599,541
- in 6 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$599,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-02 | PRYOR DANIEL A EVP, Strategy & Business Dev. | Option exercise | +6,340 | $52.02 | $330K | 170,597 |
| 2021-11-02 | PRYOR DANIEL A EVP, Strategy & Business Dev. | Sale | −6,340 | $53.02 | $336K | 164,257 |
| 2021-11-02 | PRYOR DANIEL A EVP, Strategy & Business Dev. | Option exercise · Employee Stock Option (right to buy) | −6,340 | 111,670 | ||
| 2021-10-15 | Kambeyanda Shyam ESAB President and EVP, Colfax | Option exercise | +24,644 | $24.96 | $615K | 117,189 |
| 2021-10-15 | Kambeyanda Shyam ESAB President and EVP, Colfax | Sale | −24,644 | $50.69 | $1.2M | 92,545 |
| 2021-10-15 | Kambeyanda Shyam ESAB President and EVP, Colfax | Sale | −15,218 | $50.68 | $771K | 77,327 |
| 2021-10-15 | Kambeyanda Shyam ESAB President and EVP, Colfax | Option exercise · Employee Stock Option (right to buy) | −24,644 | 0 | ||
| 2021-10-15 | Trerotola Matthew L. President & CEO | Option exercise | +50,000 | $39.54 | $2.0M | 355,708 |
| 2021-10-15 | Trerotola Matthew L. President & CEO | Sale | −37,199 | $50.61 | $1.9M | 318,509 |
| 2021-10-15 | Trerotola Matthew L. President & CEO | Sale | −12,801 | $50.88 | $651K | 305,708 |
| 2021-10-15 | Trerotola Matthew L. President & CEO | Option exercise · Employee Stock Option (right to buy) | −50,000 | 488,600 | ||
| 2021-09-30 | ALLENDER PATRICK W Director | Grant or award | +572 | 71,224 | ||
| 2021-09-30 | PERFALL A CLAYTON Director | Grant or award | +600 | 51,877 | ||
| 2021-09-30 | Wienbar Sharon L Director | Grant or award | +491 | 29,766 | ||
| 2021-09-30 | GAYNER THOMAS SINNICKSON Director | Grant or award | +491 | 64,570 | ||
| 2021-09-30 | Teirlinck Didier P Director | Grant or award | +491 | 26,038 | ||
| 2021-09-13 | Vinnakota Rajiv Director | Sale | −2,213 | $46.76 | $103K | 22,969 |
| 2021-09-13 | Trerotola Matthew L. President & CEO | Option exercise | +59,563 | $23.74 | $1.4M | 365,271 |
| 2021-09-13 | Trerotola Matthew L. President & CEO | Sale | −59,563 | $46.66 | $2.8M | 305,708 |
| 2021-09-13 | Trerotola Matthew L. President & CEO | Option exercise · Employee Stock Option (right to buy) | −59,563 | 0 |
Page 21 of 24 · 463 trades